Patent classifications
C12M27/10
Adipose tissue digestion system and tissue processing method
A tissue processing system for dissociation of and release of cellular components from adipose tissue to prepare stromal vascular fraction includes a portable tissue processing unit for containing biological material including adipose tissue during enzymatic digestion processing and a digestion drive unit configured to receive the tissue processing unit for rotational processing of the tissue processing unit about an axis of rotation. The unit has an upright orientation and a reclined orientation in which the axis of rotation is at a reclined angle to horizontal relative to the upright orientation. The digestion drive unit is configured to receive and drive rotation of the tissue processing unit in the reclined orientation. Methods for processing biological material including adipose tissue include enzymatically digesting adipose tissue with rotation of a tissue processing unit around an axis of rotation in a reclined orientation.
COMPOSITIONS, METHODS, MODULES AND INSTRUMENTS FOR AUTOMATED NUCLEIC ACID-GUIDED NUCLEASE EDITING IN MAMMALIAN CELLS VIA VIRAL DELIVERY
This invention relates to compositions of matter, methods, modules and instruments for automated mammalian cell growth and mammalian cell transduction followed by nucleic acid-guided nuclease editing in live mammalian cells.
COMPOSITIONS, METHODS, MODULES AND INSTRUMENTS FOR AUTOMATED NUCLEIC ACID-GUIDED NUCLEASE EDITING IN MAMMALIAN CELLS USING MICROCARRIERS
Compositions of matter, methods, modules, and automated instruments may relate to synthesizing a library including an editing cassette including a different gRNA and donor DNA pair, amplifying the editing cassette in a partition separate from other editing cassettes in the library, adding nuclease to the partition, and adding lipofectamine to the editing cassette and nuclease to form a lipofectamine/nucleic acid/nuclease complex. A microcarrier coated in extracellular matrix or a cell adhesion molecule coating may be added to the lipofectamine/nucleic acid/nuclease complex. Cell growth material, the microcarrier, and mammalian cells may be transferred to a growth module in an automated closed cell editing instrument via a liquid handling system. The mammalian cells may be allowed to seed on the microcarrier. Conditions may be provided for the mammalian cells to take-up and be edited by a payload associated with the lipofectamine/nucleic acid/nuclease complex. The mammalian cells may be detached from the microcarrier.
AN INCUBATOR FOR RECEIVING A NUMBER OF CELL CULTURE CHAMBER DEVICES
An incubator configured to receive a predetermined number of cell culture chamber devices, each cell culture chamber device including an enclosure configured to contain a cell culture media. The incubator has a housing including an incubation chamber configured to contain at least a respective part of the cell culture chamber devices when received by the incubator, and at least one registration and/or detection device being integrated with the incubator and being configured to register and/or detect an illumination or visualisation signal after passing, reflecting, or propagating through at least a part of the enclosure of at least one of the predetermined number of cell culture chamber devices when received by the incubator.
Cell bag rotator
A cell bag rotator is constructed to slowly agitate a plurality of cell bags by rotation along a rotation axis that is at least partially horizontal. The cell bag rotator comprises a plurality of plates to which a respective cell bag is attached. The cell bag rotator is suitable for mixing cells with particles for performing various types of subsequent cell therapy processes on the cells.
Bladeless mixer
A bladeless mixer for mixing a liquid, includes a cylindrical or truncated cone-shaped receptacle having an axis A and a radius R, the radius R being the shortest distance between the axis A and a side wall of the receptacle, the liquid to be mixed being placed in the receptacle and having an exposed surface at a height H measured along axis A; a member for tilting the receptacle such that axis A forms a non-zero-degree angle of up to 30° relative to the vertical direction; a member for imparting a rotational movement to the receptacle along axis A at an angular speed of rotation Ω; wherein the aspect ratio H/R of the height H to the radius R and the angular speed of rotation Ω are selected such that an inherent mode of inertia of the liquid has an unstable resonance when the receptacle is tilted and rotates.
System and method for generating and storing methane gas using renewable sources
Systems and methods provide a self-contained sealed apparatus that captures, filters, compresses and stores methane gas produced by the decomposition of bio-degradable organic materials. The system includes a rotatable and sealable chamber with an intermittent drive unit that mixes moist bio-degradable material during an anaerobic reaction, and captures methane gas generated by anaerobic decomposition. A filter to remove impurities, a low-pressure storage tank, a compressor and a high-pressure storage tank are interconnected and controlled by a system that monitors system parameters, that may include gas flow rate, temperature, and gas volume, and controls system parameters, that may include drive unit activation, generator operation, and compressor operation.
METHOD FOR PRODUCING CELL SHEET, CARDIOMYOCYTE SHEET, AND KIT FOR PRODUCING CARDIOMYOCYTE SHEET
A method for producing a cell sheet, the method including subjecting animal cells dispersed in a culture medium to a suspension culture while gathering the animal cells toward the center of the culture medium, to form a cell sheet floating in the culture medium.
SYSTEM, APPARATUS AND METHOD FOR THE PRODUCTION OF CELLS AND/OR CELL PRODUCTS
The present invention provides a system and a method for the production of cells and/or cell products. The system comprises at least one cell culture unit comprising at least one bioreactor for culturing cells, at least one technical control unit for controlling a cell growth parameters, said technical control unit is at least fluidly connected to the cell culture unit, and at least one air treatment unit for treating ambient air, said air treatment unit is fluidly connected to the cell culture unit. The system is characterized in that the system is autonomous and the bioreactor total volume is at most 1000L.
MICROFLUIDIC DEVICE FOR CEREBROVASCULAR SIMULATION AND HIGH-EFFICIENCY BLOOD-BRAIN BARRIER SIMULATION SYSTEM COMPRISING SAME
The present disclosure provides a microfluidic device for simulating a blood-brain barrier and a blood-brain barrier simulation system including the same, and the microfluidic device includes: a first channel; a second channel which is adjacently connected to the first channel through one or more microholes and configured to culture neural stem cells; and a chamber which is connected to both ends of the first channel and contains a culture medium.